SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-091475
Filing Date
2020-08-06
Accepted
2020-08-06 16:32:23
Documents
45
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tmb-20200630x10q.htm   iXBRL 10-Q 1307492
2 EXHIBIT 31.1 tmb-20200630xex31d1.htm EX-31.1 12582
3 EXHIBIT 31.2 tmb-20200630xex31d2.htm EX-31.2 13049
4 EXHIBIT 32.1 tmb-20200630xex32d1.htm EX-32.1 6635
5 EXHIBIT 32.2 tmb-20200630xex32d2.htm EX-32.2 6605
  Complete submission text file 0001104659-20-091475.txt   4100284

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tmb-20200630.xsd EX-101.SCH 31208
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20200630_cal.xml EX-101.CAL 21340
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20200630_def.xml EX-101.DEF 130239
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20200630_lab.xml EX-101.LAB 217567
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20200630_pre.xml EX-101.PRE 207316
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20200630x10q_htm.xml XML 592355
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 201082235
SIC: 2834 Pharmaceutical Preparations